| |
|
Form Serial Number: |
DA20230621E00344
|
| 1.
Date of relevant event: |
16/06/2023
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02096 |
| 4.
Name of listed corporation: |
Simcere Pharmaceutical Group Ltd. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
2,664,045,618 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
REN |
| (Other names) |
JINSHENG |
|
|
|
| 10.
Name of director (Chinese): |
任晉生 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
360,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 1,845,518,913 | 69.28 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 1,845,158,913 | 69.26 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| | Long position | 1,602,760,965 |
|
| 2202 | Interest of your spouse |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| Spouse | Wang Xi | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Simcere Investments Group Limited ("SIG") | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands | Ren Jinsheng | 100.00 | Y | |
| Fortune Fountain Investment Limited | Room 1903, 19/F., Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong | Ren Jinsheng | 76.06 | Y | |
| Simcere Investments Group Limited ("SIG") | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands | Ren Jinsheng | 100.00 | N | |
| STATE GOOD GROUP LIMITED | Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands | Simcere Investments Group Limited | 100.00 | N | |
| Nanjing BioSciKin TechnologyDevelopment Co., Ltd ("NBTD") | No. 22-34, Dangui Road, Pukou District, Nanjing,Jiangsu, PRC | STATE GOOD GROUP LIMITED | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Ms. Peng Suqin, who is deemed to be acting in concert with Mr. Ren Jinsheng ("Mr. Ren") under the Takeovers Code, sold 360,000 shares, leading to a decrease in Mr. Ren's percentage of interest. After the event, Mr. Ren, together with parties who are deemed to be persons acting in concert, collectively and indirectly hold 1,844,666,913 shares and is deemed to be interested in (i) 164,000 shares held by Wang Xi; and (ii) 328,000 shares underlying the RSUs granted to Wang Xi.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
21/06/2023
(dd/mm/yyyy)
|
| |